Literature DB >> 25085607

Effect of combined cognitive-behavioural therapy and endurance training on cortisol and salivary alpha-amylase in panic disorder.

Jens Plag1, Katharina Gaudlitz2, Sarah Schumacher1, Fernando Dimeo3, Thomas Bobbert4, Clemens Kirschbaum5, Andreas Ströhle1.   

Abstract

Current data point to an alteration of both the hypothalamo-pituitary-adrenal (HPA)-system and the peripheral transmission of catecholamines in anxiety disorders. There is also some evidence for the effect of several components of cognitive-behavioural interventions such as coping and control and for an effect of exercise training on the neuroendocrine stress response in healthy subjects as well as patients suffering from distinct (mental) disorders. This double-blind, controlled study investigated the effect of cognitive-behavioural therapy (CBT) in combination with either high-level endurance training or low-level exercise on salivary cortisol (sC) and on levels of salivary alpha-amylase (sAA) in patients suffering from panic disorder (PD) with and without agoraphobia. In comparison to the low-level exercise condition, there were significantly lower sC-levels in the experimental group performing high-level endurance training at a 7-month follow-up. In contrast, there were no group differences in sAA levels during the study period. In this trial, we found evidence for a decelerated effect of endurance-training on HPA-system's functioning in PD. Further studies addressing the alteration of sAA levels in this population might investigate physical exercise different in intensity and duration.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive behavioural therapy (CBT); Cortisol; HPA-system; Panic disorder; Physical activity; Salivary alpha amylase

Mesh:

Substances:

Year:  2014        PMID: 25085607     DOI: 10.1016/j.jpsychires.2014.07.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

Review 1.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 2.  Why Does Psychotherapy Work and for Whom? Hormonal Answers.

Authors:  Susanne Fischer; Sigal Zilcha-Mano
Journal:  Biomedicines       Date:  2022-06-09

3.  Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol.

Authors:  Carlos A Soria; Carolina Remedi; Daniel A Núñez; Luciana D'Alessio; Emilio J A Roldán
Journal:  BMJ Open       Date:  2015-07-14       Impact factor: 2.692

4.  The impact of an exercise training intervention on cortisol levels and post-traumatic stress disorder in juveniles from an Ugandan refugee settlement: study protocol for a randomized control trial.

Authors:  Henning Budde; Davin P Akko; Herbert E Ainamani; Eric Murillo-Rodríguez; Roland Weierstall
Journal:  Trials       Date:  2018-07-09       Impact factor: 2.279

5.  Interval Training Improves Depressive Symptoms But Not Anxious Symptoms in Healthy Women.

Authors:  Ricardo Borges Viana; Paulo Gentil; João Pedro Araújo Naves; Ana Cristina Silva Rebelo; Douglas Assis Teles Santos; Marco Aurélio Oliveira Braga; Claudio Andre Barbosa de Lira
Journal:  Front Psychiatry       Date:  2019-09-12       Impact factor: 4.157

6.  Cortisol response under low intensity exercise during cognitive-behavioral therapy is associated with therapeutic outcome in panic disorder-an exploratory study.

Authors:  Gloria-Beatrice Wintermann; René Noack; Susann Steudte-Schmiedgen; Kerstin Weidner
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

Review 7.  Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review.

Authors:  Richella Ryan; Sara Booth; Anna Spathis; Sarah Mollart; Angela Clow
Journal:  Ann Behav Med       Date:  2016-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.